The Claim

In obese mice, administration of G49 increases circulating fibroblast growth factor 21 (FGF21) levels by 3- to 4-fold within 12 hours through glucagon receptor-dependent activation of hepatic ketogenesis, and this elevation is necessary for the full activation of brown adipose tissue and sustained weight loss.

Source: The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
66score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In obese mice, a compound called G49 triggers a 3- to 4-fold rise in FGF21 hormone levels within 12 hours by activating fat breakdown in the liver via the glucagon receptor. This rise in FGF21 is required to fully activate brown fat and maintain long-term weight loss.

See the scientific wording

In obese mice, G49 increases circulating fibroblast growth factor 21 (FGF21) levels by 3- to 4-fold within 12 hours, primarily through glucagon receptor-dependent activation of hepatic ketogenesis, and this elevation is required for full activation of brown adipose tissue and sustained weight loss.

Why this might work

A drug triggers a receptor in fat tissue that causes fat to break down and release fatty acids into the blood. These fatty acids go to the liver, where they are burned for energy in a way that produces ketones. This process tells the liver to make a hormone called FGF21, which travels to brown fat and turns on a protein that burns energy as heat instead of storing it. This heat production causes the body to lose weight.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk

    G49 is a drug that tricks the body into thinking it’s had surgery, making the liver release a hormone called FGF21. This hormone wakes up brown fat to burn more calories, helping mice lose weight — and it all starts with the glucagon receptor.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.